Healthcare

Global Hepatitis A Vaccine Market Valuable Growth Prospects, Top Players, Key Country Analysis, Trends and Forecast till 2024

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Two types of HAV vaccines are currently available internationally:

  1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in pediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
  2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.

Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

According to this study, over the next five years the Hepatitis A Vaccine market will register a 2.8% CAGR in terms of revenue, the global market size will reach US$ 770 million by 2024, from US$ 650 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hepatitis A Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis A Vaccine market by product type, application, key manufacturers and key regions and countries.

This study considers the Hepatitis A Vaccine value and volume generated from the sales of the following segments:

Get more information, Ask for free sample copy: https://www.reportocean.com/industry-verticals/sample-request.php?report_id=19466

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3: and forecast to 2024 in section 11.7.

  • Inactivated Vaccine
  • Live Attenuated Vaccine

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4: and forecast to 2024 in section 11.8.

  • Government Institution
  • Private Sector
  • Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Spain
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
  • GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

  • GSK
  • Merck
  • Sanofi
  • Sinovac
  • Zhejiang Pukang
  • Changchun Institute of Biological
  • Kaketsuken
  • IMBCA
  • ChangSheng
  • Convac

Access this Report: https://www.reportocean.com/industry-verticals/sample-request.php?report_id=19466

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

 

Research objectives

  • To study and analyze the global Hepatitis A Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
  • To understand the structure of Hepatitis A Vaccine market by identifying its various subsegments.
  • Focuses on the key global Hepatitis A Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Hepatitis A Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Hepatitis A Vaccine submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.

 

About us:

We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom-line goals which will boost your market share in today’s competitive environment. Report Ocean is ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports. We will help you in finding the upcoming trends that will entitle you as a leader in the industry. We are here to work with you on your objective which will create an immense opportunity for your organization.

Contact us:
Company Name: Report Ocean
Address: Classic Tower, Rajnagar Extension, Ghaziabad, 201017 – India
Contact: +1 888 212 3539 (US) +91-9997112116 (Outside US)
Contact Person: Sandeep Singh
URL: www.reportocean.com
Email: [email protected]